Taiwan FDA registration f0e7cb6f82cbce40945553b76a842f61

Vitingpi high-end platelet concentrate separation tube

TW: 威挺倍高端型血小板濃縮液分離管

Taiwan·Risk Class 2·TCM BIOTECH INTERNATIONAL CORP.·Registered Jun 20, 2018 – Jun 20, 2028Active

Registration details

Analysis ID: f0e7cb6f82cbce40945553b76a842f61

Company information

Manufacturer: TCM BIOTECH INTERNATIONAL CORP.
Manufacturer Country: Taiwan, Province of China
Authorized Representative: TCM BIOTECH INTERNATIONAL CORP.

Product details

Intended Use: This product uses vacuum blood collection to draw a small amount of peripheral blood from the patient, and centrifuge to prepare platelet-rich plasma (PRP).
Product Type (Level 1): B Hematology, pathology, and genetics
Product Type (Level 2): B.9245 Automated hemocytoseparator
Import Information: Domestic;; Contract manufacturing

Dates and status

Registration Date: Jun 20, 2018
Expiry Date: Jun 20, 2028

About this record

Access comprehensive regulatory information for Vitingpi high-end platelet concentrate separation tube in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number f0e7cb6f82cbce40945553b76a842f61 and manufactured by TCM BIOTECH INTERNATIONAL CORP.. The authorized representative in Taiwan is TCM BIOTECH INTERNATIONAL CORP..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.